Hemostatic disturbances in acute ischemic stroke

P Siljander, O Carpen, R Lassila, Platelet-Derived Microparticles Associate With Fibrin During Thrombosis Blood. ,vol. 87, pp. 4651- 4663 ,(1996) , 10.1182/BLOOD.V87.11.4651.BLOODJOURNAL87114651

Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke prevention in Atrial Fibrillation III Randomised Clinical Trial The Lancet. ,vol. 348, pp. 633- 638 ,(1996) , 10.1016/S0140-6736(96)03487-3

Marco R. Di Tullio, Shunichi Homma, Zhezhen Jin, Ralph L. Sacco, Aortic Atherosclerosis, Hypercoagulability, and Stroke: The APRIS (Aortic Plaque and Risk of Ischemic Stroke) Study Journal of the American College of Cardiology. ,vol. 52, pp. 855- 861 ,(2008) , 10.1016/J.JACC.2008.04.062

C A Owen, Usefulness of routine prothrombin-time measurements. Clinical Chemistry. ,vol. 23, pp. 613- 613 ,(1977) , 10.1093/CLINCHEM/23.3.613

K M Brinkhous, R H Wagner, R D Langdell, Effect of antihemophilic factor on one-stage clotting tests; a presumptive test for hemophilia and a simple one-stage antihemophilic factor assy procedure. Journal of Laboratory and Clinical Medicine. ,vol. 41, pp. 637- 647 ,(1953)

Josef Finsterer, Management of cryptogenic stroke. Acta Neurologica Belgica. ,vol. 110, pp. 135- 147 ,(2010)

J. Hou, Y. Fu, J. Zhou, W. Li, R. Xie, F. Cao, G. E. Gilbert, J. Shi, Lactadherin functions as a probe for phosphatidylserine exposure and as an anticoagulant in the study of stored platelets Vox Sanguinis. ,vol. 100, pp. 187- 195 ,(2011) , 10.1111/J.1423-0410.2010.01375.X

F. W. G. LEEBEEK, M. P. J. GOOR, A. H. C. GUIMARAES, G.-J. BROUWERS, M. P. M. MAAT, D. W. J. DIPPEL, D. C. RIJKEN, High functional levels of thrombin-activatable fibrinolysis inhibitor are associated with an increased risk of first ischemic stroke. Journal of Thrombosis and Haemostasis. ,vol. 3, pp. 2211- 2218 ,(2005) , 10.1111/J.1538-7836.2005.01484.X

Margareta Blombäck, Shu He, Niklas Bark, Håkan N. Wallen, Margareta Elg, Effects on fibrin network porosity of anticoagulants with different modes of action and reversal by activated coagulation factor concentrate. British Journal of Haematology. ,vol. 152, pp. 758- 765 ,(2011) , 10.1111/J.1365-2141.2010.08546.X

M. SMID, A. W. J. H. DIELIS, M. WINKENS, H. M. H. SPRONK, R. VAN OERLE, K. HAMULYÁK, M. H. PRINS, J. ROSING, J. L. WALTENBERGER, H. TEN CATE, Thrombin generation in patients with a first acute myocardial infarction Journal of Thrombosis and Haemostasis. ,vol. 9, pp. 450- 456 ,(2011) , 10.1111/J.1538-7836.2010.04162.X